![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, June 15, 2013 1:29:42 PM
These are the next two catalysts (date and information due out by end of Q2):
1) Gene Therapy data related to MANF
2) Orphan indications related to both the Eye and Ear (tied to MANF as well).
and one other MANF catalyst could happen too:
3) MJFF grant
Gerald confirmed these realities in the most recent Marcum presentations a short while back except for an MJFF grant (listen to the webcast).
Anybody have a few million to loan to Gerald..this dilutive financing is getting old and destructive to shareholders!
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM